ARS Pharma (SPRY) Cuts Spending As It Chases Neffy Market Share
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset?
Key PointsInvesco Biotechnology & Genome ETF focuses on 31 companies selected via a quantitative index based on factors like momentum and earnings growth.
i-80 Gold CEO Richard Scott Young Buys 1 Million Shares. What Does This Mean for Investors?
Young's direct equity holdings jumped 20% as stock surged 123% over trailing twelve months, signaling executive confidence in Nevada gold and silver operations.
Anthropic IPO filing will show AI backlash as a risk factor, sources say
Anthropic is poised to debut on the stock market at a time when the public is increasingly upset about data centers and is fearful about AI taking jobs.
Crypto advocates join in suing Illinois over digital asset tax
The Crypto Council for Innovation and the Blockchain Association added another lawsuit against the state for its recently approved 0.2% crypto tax.
Why Did Critical Metals Stock Just Gain 22.6%?
Key PointsCritical Metals stock closed 22.6% higher on Aug. 21, 2026, after management reaffirmed that its Tanbreez project in Greenland is on schedule to produce rare-earth elements within three…